Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid.
Ghiglieri V, Sgobio C, Patassini S, Bagetta V, Fejtova A, Giampà C, Marinucci S, Heyden A, Gundelfinger ED, Fusco FR, Calabresi P, Picconi B. Ghiglieri V, et al. Among authors: patassini s. Neuropsychopharmacology. 2010 Jun;35(7):1531-40. doi: 10.1038/npp.2010.23. Epub 2010 Mar 3. Neuropsychopharmacology. 2010. PMID: 20200504 Free PMC article.
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease.
DeMarch Z, Giampà C, Patassini S, Bernardi G, Fusco FR. DeMarch Z, et al. Among authors: patassini s. Neurobiol Dis. 2008 Jun;30(3):375-387. doi: 10.1016/j.nbd.2008.02.010. Epub 2008 Mar 7. Neurobiol Dis. 2008. PMID: 18424161
We have previously showed that rolipram, a phosphodiesterase type IV inhibitor, displays a neuroprotective effect in a rat quinolinic acid model of HD [DeMarch Z., Giampa C., Patassini S., Martorana A., Bernardi G. and Fusco F.R., (2007) Beneficial effects of rolipr …
We have previously showed that rolipram, a phosphodiesterase type IV inhibitor, displays a neuroprotective effect in a rat quinolinic acid m …
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
Giampà C, Middei S, Patassini S, Borreca A, Marullo F, Laurenti D, Bernardi G, Ammassari-Teule M, Fusco FR. Giampà C, et al. Among authors: patassini s. Eur J Neurosci. 2009 Mar;29(5):902-10. doi: 10.1111/j.1460-9568.2009.06649.x. Eur J Neurosci. 2009. PMID: 19291221
Cellular localization of TRPC5 in the substantia nigra of rat.
De March Z, Giampà C, Patassini S, Bernardi G, Fusco FR. De March Z, et al. Among authors: patassini s. Neurosci Lett. 2006 Jul 10;402(1-2):35-9. doi: 10.1016/j.neulet.2006.03.061. Epub 2006 Apr 25. Neurosci Lett. 2006. PMID: 16635549
Immunohistochemical localization of TRPC6 in the rat substantia nigra.
Giampà C, DeMarch Z, Patassini S, Bernardi G, Fusco FR. Giampà C, et al. Among authors: patassini s. Neurosci Lett. 2007 Sep 13;424(3):170-4. doi: 10.1016/j.neulet.2007.07.049. Epub 2007 Aug 9. Neurosci Lett. 2007. PMID: 17723267
Neurosci. 2 (2001) 387-396; A. Martorana, C. Giampa, Z. DeMarch, M.T. Viscomi, S. Patassini, G. Sancesario, G. Bernardi, F.R. Fusco, Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study, Eur. ...
Neurosci. 2 (2001) 387-396; A. Martorana, C. Giampa, Z. DeMarch, M.T. Viscomi, S. Patassini, G. Sancesario, G. Bernardi, F.R. …
37 results